Company intelligence / Profile preview
Nanopharmaceutics, Inc.
Alachua, Florida, USApmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Nanopharmaceutics is a clinical-stage specialty pharmaceutical company leveraging proprietary nanoparticle technologies to develop oral, topical, and injectable therapies for cancer, CNS disorders, diabetes, and infectious diseases. The company has advanced its lead candidate into a Phase 3 trial for cervical/vaginal cancer using triapine plus cisplatin chemoradiation. It also collaborates with PrecisionLife to optimize patient selection in CNS trials using genetic biomarkers.[1][3][5][6]
- Therapeutic areas
- OncologyEndocrinologyNeurologyInfectious Diseases
- Modalities
- Small molecules (notably nanoparticle and fine-particle formulations)[1][5]Oral, topical, and injectable drug products[1][3]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
PrecisionLife Ltd. – strategic collaboration for biomarker-driven CNS drug development using combinatorial analytics platform [6]
Beyond the preview
Go deeper on Nanopharmaceutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanopharmaceutics, Inc..